<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5845707</article-id><article-id pub-id-type="doi">10.3389/fimmu.2018.00448</article-id><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Next-Generation Sequencing Analysis of the Human TCR&#x003b3;&#x003b4;+ T-Cell Repertoire Reveals Shifts in V&#x003b3;- and V&#x003b4;-Usage in Memory Populations upon Aging</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kallemeijn</surname><given-names>Martine J.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kavelaars</surname><given-names>Fran&#x000e7;ois G.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>van der Klift</surname><given-names>Mich&#x000e8;le Y.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wolvers-Tettero</surname><given-names>Ingrid L. M.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Valk</surname><given-names>Peter J. M.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>van Dongen</surname><given-names>Jacques J. M.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn001"><sup>&#x02020;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Langerak</surname><given-names>Anton W.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/29407"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Laboratory for Medical Immunology, Department of Immunology, Erasmus University Medical Center</institution>, <addr-line>Rotterdam</addr-line>, <country>Netherlands</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Hematology, Erasmus University Medical Center</institution>, <addr-line>Rotterdam</addr-line>, <country>Netherlands</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Rafael Solana, Universidad de C&#x000f3;rdoba, Spain</p></fn><fn fn-type="edited-by"><p>Reviewed by: Roberto Spreafico, Synthetic Genomics, United States; Hassen Kared, Singapore Immunology Network (A*STAR), Singapore; Kilian Wistuba-Hamprecht, Universit&#x000e4;tsklinikum T&#x000fc;bingen, Germany</p></fn><corresp content-type="corresp" id="cor1">*Correspondence: Anton W. Langerak, <email>a.langerak@erasmusmc.nl</email></corresp><fn fn-type="present-address" id="fn001"><p><sup>&#x02020;</sup>Present address: Jacques J. M. van Dongen, Department of Immunohematology and Blood Transfusion (IHB), LUMC, Leiden, Netherlands</p></fn><fn fn-type="other" id="fn002"><p>Specialty section: This article was submitted to Inflammation, a section of the journal Frontiers in Immunology</p></fn></author-notes><pub-date pub-type="epub"><day>06</day><month>3</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>9</volume><elocation-id>448</elocation-id><history><date date-type="received"><day>31</day><month>10</month><year>2017</year></date><date date-type="accepted"><day>19</day><month>2</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 Kallemeijn, Kavelaars, van der Klift, Wolvers-Tettero, Valk, van Dongen and Langerak.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Kallemeijn, Kavelaars, van der Klift, Wolvers-Tettero, Valk, van Dongen and Langerak</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Immunological aging remodels the immune system at several levels. This has been documented in particular for the T-cell receptor (TCR)&#x003b1;&#x003b2;+ T-cell compartment, showing reduced naive T-cell outputs and an accumulation of terminally differentiated clonally expanding effector T-cells, leading to increased proneness to autoimmunity and cancer development at older age. Even though TCR&#x003b1;&#x003b2;+ and TCR&#x003b3;&#x003b4;+ T-cells follow similar paths of development involving V(D)J-recombination of TCR genes in the thymus, TCR&#x003b3;&#x003b4;+ T-cells tend to be more subjected to peripheral rather than central selection. However, the impact of aging in shaping of the peripheral TRG/TRD repertoire remains largely elusive. Next-generation sequencing analysis methods were optimized based on a spike-in method using plasmid vector DNA-samples for accurate TRG/TRD receptor diversity quantification, resulting in optimally defined primer concentrations, annealing temperatures and cycle numbers. Next, TRG/TRD repertoire diversity was evaluated during TCR&#x003b3;&#x003b4;+ T-cell ontogeny, showing a broad, diverse repertoire in thymic and cord blood samples with Gaussian CDR3-length distributions, in contrast to the more skewed repertoire in mature circulating TCR&#x003b3;&#x003b4;+ T-cells in adult peripheral blood. During aging the naive repertoire maintained its diversity with Gaussian CDR3-length distributions, while in the central and effector memory populations a clear shift from young (V&#x003b3;9/V&#x003b4;2 dominance) to elderly (V&#x003b3;2/V&#x003b4;1 dominance) was observed. Together with less clear Gaussian CDR3-length distributions, this would be highly suggestive of differentially heavily selected repertoires. Despite the apparent age-related shift from V&#x003b3;9/V&#x003b4;2 to V&#x003b3;2/V&#x003b4;1, no clear aging effect was observed on the V&#x003b4;2 invariant T nucleotide and canonical V&#x003b3;9&#x02013;J&#x003b3;1.2 selection determinants. A more detailed look into the healthy TRG/TRD repertoire revealed known cytomegalovirus-specific TRG/TRD clonotypes in a few donors, albeit without a significant aging-effect, while <italic>Mycobacterium tuberculosis</italic>-specific clonotypes were absent. Notably, in effector subsets of elderly individuals, we could identify reported TRG and TRD receptor chains from TCR&#x003b3;&#x003b4;+ T-cell large granular lymphocyte leukemia proliferations, which typically present in the elderly population. Collectively, our results point to relatively subtle age-related changes in the human TRG/TRD repertoire, with a clear shift in V&#x003b3;/V&#x003b4; usage in memory cells upon aging.</p></abstract><kwd-group><kwd>TCR&#x003b3;&#x003b4;+</kwd><kwd>development</kwd><kwd>aging</kwd><kwd>repertoire</kwd><kwd>next-generation sequencing</kwd></kwd-group><funding-group><award-group><funding-source id="cn01">Roche<named-content content-type="fundref-id">10.13039/100004337</named-content></funding-source><award-id rid="cn01">Unrestricted grant</award-id></award-group></funding-group><counts><fig-count count="5"/><table-count count="1"/><equation-count count="0"/><ref-count count="62"/><page-count count="12"/><word-count count="8282"/></counts></article-meta></front><body><sec sec-type="introduction" id="S1"><title>Introduction</title><p>Immunological aging, also referred to as immunosenescence, is a complex phenomenon consisting of senescence and exhaustion processes, which are characterized by different functional and marker expression profiles (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>). Immunosenescence acts on different levels in the immune system, e.g., reduced antigen-specific responses (<xref rid="B3" ref-type="bibr">3</xref>), thymic shrinkage, and a significantly reduced naive T-cell output (<xref rid="B3" ref-type="bibr">3</xref>&#x02013;<xref rid="B5" ref-type="bibr">5</xref>), convergence of the innate and adaptive immunity (<xref rid="B6" ref-type="bibr">6</xref>), and ultimately T-cell exhaustion (<xref rid="B1" ref-type="bibr">1</xref>). Immunosenescence is believed to play a major role in shaping of the antigen receptor repertoire of T-cells.</p><p>T-cells develop in the thymus, where they undergo commitment, rearrangement, selection and maturation processes. The main event during T-cell development is the rearrangements of the variable (V), diversity (D), and joining (J) genes of the T-cell receptor (TR) loci, in order to establish a large diversity of antigen receptors (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>). Two main types of T-cells are generated; first, TCR&#x003b3;&#x003b4;+ thymocytes, through early TR delta and gamma (TRD, TRG) rearrangements, then followed by TCR&#x003b1;&#x003b2;+ thymocytes upon TR beta and alpha (TRB, TRA) rearrangements (<xref rid="B8" ref-type="bibr">8</xref>). TCR&#x003b1;&#x003b2;+ thymocytes undergo positive selection through TCR signaling to subsequently mature into functional T-cells, followed by negative selection in order to eliminate self-reactive T-cell precursors (<xref rid="B9" ref-type="bibr">9</xref>). In contrast, TCR&#x003b3;&#x003b4;+ thymocytes do not undergo positive and/or negative selection in the thymus (<xref rid="B10" ref-type="bibr">10</xref>), but extrathymic development and peripheral (antigenic) selection of TCR&#x003b3;&#x003b4;+ T-cells have been described (<xref rid="B11" ref-type="bibr">11</xref>).</p><p>TCR&#x003b3;&#x003b4;+ T-cells appear to be the first functional population of circulating T lymphocytes in both murine and human peripheral blood (PB) [reviewed in Ref. (<xref rid="B12" ref-type="bibr">12</xref>)]. In the human fetal and neonatal situation these functional circulating TCR&#x003b3;&#x003b4;+ T-cells mainly concern V&#x003b4;1+ cells. Readily after birth and during further development to adulthood a switch occurs in the circulating TCR&#x003b3;&#x003b4;+ T-cell population with the number of V&#x003b4;1+ cells decreasing and V&#x003b3;9/V&#x003b4;2 cells becoming the predominant TCR&#x003b3;&#x003b4;+ T-cell types (<xref rid="B13" ref-type="bibr">13</xref>). This process is believed to be the result of peripheral antigenic selection, exemplified by the presence of an invariant T nucleotide in the majority of the selected V&#x003b4;2&#x02013;J&#x003b4;1 rearrangements (<xref rid="B13" ref-type="bibr">13</xref>&#x02013;<xref rid="B15" ref-type="bibr">15</xref>). Furthermore, epitopes from pathogens or other antigens that could stimulate and select TCR&#x003b3;&#x003b4;+ T-cell types have been described: <italic>Mycobacterium tuberculosis</italic> has been found to be a major stimulator of V&#x003b3;9/V&#x003b4;2 cells in both infected lungs and PB (<xref rid="B16" ref-type="bibr">16</xref>), whereas non-V&#x003b3;9/V&#x003b4;1 cells are known to be stimulated by viruses, such as cytomegalovirus (CMV) (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B18" ref-type="bibr">18</xref>) and Epstein-Bar virus (EBV) (<xref rid="B19" ref-type="bibr">19</xref>). TCR&#x003b3;&#x003b4;+ T-cells do not only recognize antigens <italic>via</italic> their receptor, but they also respond to lipid antigens presented on CD1d-molecules, and that are associated with stress, inflammation and cancer [reviewed by Ref. (<xref rid="B20" ref-type="bibr">20</xref>)]. Most TCR&#x003b3;&#x003b4;+ T-cells recognizing these CD1d-lipid antigen complexes are V&#x003b4;1 or V&#x003b4;3 cells, commonly located in the gut (<xref rid="B21" ref-type="bibr">21</xref>). TCR&#x003b3;&#x003b4;+ T-cells can also recognize butyrophilins, tumor-antigens, endothelial antigens, antigen-presenting cells, and Toll-like receptors [reviewed in Ref. (<xref rid="B22" ref-type="bibr">22</xref>)], all of which are postulated to contribute to shaping of the TCR&#x003b3;&#x003b4;+ T-cell repertoire.</p><p>TCR&#x003b3;&#x003b4;+ T-cell recognition and selection has been mostly described in the context of the developing immune system from fetus to neonate and adulthood, but&#x02014;contrary to the TCR&#x003b1;&#x003b2;+ T-cell repertoire&#x02014;effects of aging on the TCR&#x003b3;&#x003b4;+ T-cell repertoire have not been extensively addressed. Since it has been found that TCR&#x003b3;&#x003b4;+ T-cells follow the classical aging model as found in mainly CD8+ TCR&#x003b1;&#x003b2;+ T-cells (<xref rid="B23" ref-type="bibr">23</xref>), we hypothesized that the naive mature TCR&#x003b3;&#x003b4;+ T-cell repertoire would depict a broad spectrum of rearrangements and that it would show a more skewed pattern during further development from neonates to young adults and eventually elderly individuals. Furthermore, in view of the fact that T-cell large granular lymphocyte (LGL) leukemia typically presents as a proliferation of effector cells in elderly, we were interested to compare our TRG/TRD repertoire findings to the LGL clonal repertoire. To this end, we investigated the developing and aging TRG/TRD repertoire in TCR&#x003b3;&#x003b4;+ T-cell subsets, using an optimized experimental next-generation sequencing (NGS) procedure to minimize technical biases of PCR-based methods. Our data show subset- and donor-specific TRG/TRD repertoires, suggestive of selection, with significant differences in the combinatorial repertoire in especially memory populations between young and elderly individuals. When looking closer into TRG/TRD clonotypes, TCR&#x003b3;&#x003b4;+ T-LGL leukemia receptor chains could be traced in especially the effector subsets of elderly individuals, which would fit the current idea that TCR&#x003b3;&#x003b4;+ T-LGL leukemia cells originate from the normal healthy antigen-experienced TCR&#x003b3;&#x003b4;+ T-cells.</p></sec><sec sec-type="materials|methods" id="S2"><title>Materials and Methods</title><sec id="S2-1"><title>Subjects and Materials</title><p>Blood from healthy blood donors from Sanquin Blood Bank (Amsterdam, The Netherlands) in the age range of 20&#x02013;35&#x02009;years (young adults, <italic>N</italic>&#x02009;=&#x02009;11) and 56&#x02013;70&#x02009;years (elderly, <italic>N</italic>&#x02009;=&#x02009;12) was used upon written informed consent at the blood bank (project number NVT0012.01) and anonymized for further use. The maximum age to donate blood is 70&#x02009;years. Healthy neonatal cord blood (CB) was obtained postpartum or after Caesarian section through collaboration and upon written informed consent at the Departments of Obstetrics and Hematology. CB was drawn using CB Collect bags containing citrate phosphate dextrose solution as anticoagulant. Thymic lobes were removed upon heart surgery in individuals under the age of two years upon written informed consent from parents. Both CB and thymus material was obtained under Medical Ethics Committee approval (project number hmPOO2004-003). Whole thymic material was sliced and prepared prior to cryopreservation. Peripheral blood mononuclear cells (PBMCs) and cord blood mononuclear cells (CBMCs) were obtained through Ficoll density gradient separation. Isolated PBMCs, CBMCs, and thymocytes were cryopreserved in Iscove&#x02019;s Modified Dulbecco&#x02019;s Medium (Lonza, Basel, Switzerland) with dimethyl sulfoxide and stored in vials at &#x02212;180&#x000b0;C until further use. All studies were conducted in accordance with the principles of the Declaration of Helsinki.</p></sec><sec id="S2-2"><title>Cell Sorting</title><p>Cryopreserved material was thawed and sorted using CD3, CD45, TCR&#x003b1;&#x003b2;, TCR&#x003b3;&#x003b4;, CD45RA, CD45RO, CD27, and CD197 antibodies (Table S1 in Supplementary Material) to obtain TCR&#x003b3;&#x003b4;+ naive (CD45RA+ CD27+ CD197&#x02009;+), central memory (CD45RA-CD45RO+ CD27+ CD197+), effector memory (Temro population defined as CD45RA-CD45RO+ CD27&#x02212; CD197&#x02212;), and effector (Temra population, CD45RA+ CD27&#x02212; CD197&#x02212;) T-cells (Figure S1 in Supplementary Material). Cell sorting was performed with FACS Aria I and III instruments (BD Biosciences, San Jose, CA, USA).</p></sec><sec id="S2-3"><title>DNA Isolation</title><p>Following isolation, cells were lysed and subjected to DNA isolation using the DNA/RNA/miRNA AllPrepKit according to the manufacturer&#x02019;s protocol (Qiagen, Hilden, Germany). DNA concentration and quality (A260/A280 absorption ratio) were determined by Nanodrop measurements (Thermo Fischer Scientific, Waltham, MA, USA).</p></sec><sec id="S2-4"><title>Primer Design</title><p>Primers for cloning and Illumina-based sequencing were largely based on those reported in BIOMED-2 assays (<xref rid="B24" ref-type="bibr">24</xref>). The V&#x003b4;3 primer was redesigned to better fit amplicon length of PCR products generated with the existing V&#x003b4;1 and V&#x003b4;2 primers. The J&#x003b3;1.2 primer was newly designed, as this primer was not included in the BIOMED-2 TRG assay. V&#x003b3;1F and J&#x003b3;1.3/2.3 primers were adjusted compared with the BIOMED-2 protocol (Table S2 in Supplementary Material). Primers were adapted for Illumina-based sequencing by adding Illumina forward (5&#x02032;-ACACTCTTTCCCTACACGACGCTCTTCCGATCT-3&#x02032;) and reverse (5&#x02032;-TCGCGAGTTAATGCAACGATCGTCGAAATTCGC-3&#x02032;) overhang adaptor sequences to the respective primers. The second PCR, by means of these overhang adaptor sequences, attaches sample-specific dual indices for sample identification and Illumina sequencing adaptors using primers from the Illumina TruSeq Custom Amplicon Index Kit (Illumina, San Diego, CA, USA).</p></sec><sec id="S2-5"><title>Plasmid Pool Preparation</title><p>Primer validation and titration was done using plasmid vectors with cloned TRD and TRG gene rearrangements. All possible V&#x02013;J gene combinations were PCR amplified and cloned from immature T-cell lines (<xref rid="B25" ref-type="bibr">25</xref>) and thymus DNA into the pGEM T-Easy vector in a 3:1 insert:vector ratio according to the manufacturer&#x02019;s protocol (Promega, Madison, WI, USA). Composition of the plasmid pools is summarized in Table S3 in Supplementary Material.</p></sec><sec id="S2-6"><title>Assay Optimization Experiments</title><p>PCRs were first tested in singleplex and multiplex settings with varying primer concentrations, annealing temperatures and PCR cycle numbers. Each initial PCR mix contained GeneAmp PCR Buffer II (1&#x000d7;), magnesium chloride (2.5&#x02009;mM), dNTPs (2.0&#x02009;mM), and AmpliTaqGold (1&#x02009;U) (Thermo Fischer Scientific). Total forward and reverse primer(s) amounts were generally 10&#x02009;pmol. The PCR protocol was largely based on the BIOMED-2 publication (<xref rid="B23" ref-type="bibr">23</xref>), with varying annealing temperatures (Tm&#x02009;=&#x02009;58/59/60/62) and different numbers of cycles (20 and 25 cycles). Primer concentration adjustment, and optimization of annealing temperatures and number of PCR cycles were based on the results of iterative optimization experiments as summarized in Table S4 and Figures S2 and S3 in Supplementary Material.</p></sec><sec id="S2-7"><title>Amplicon Preparation</title><p>Amplicons from the first step PCR were purified using the Agencourt AMPure XP bead purification kit (Beckman Coulter, Fullerton, CA, USA), whereafter concentrations were measured with the Quant-iT PicoGreen dsDNA Assay Kit (Thermo Fischer Scientific), after which the amplicons were adjusted to similar concentrations. The second step PCR was performed with primers from the Illumina TruSeq Custom Amplicon Index Kit (Illumina) using the KAPA HiFi HotStart PCR Kit (Kapa Biosystems, Wilmington, MA, USA). Second PCR amplicons were evaluated <italic>via</italic> agarose gel electrophoresis or PicoGreen concentration measure-ment. Library pool preparation was subsequently performed based on the gel image or PicoGreen measurement results. The library pool was further purified with Agencourt AMPure XP beads and normalized for Illumina-based sequencing, according to the manufacturer&#x02019;s protocol (Illumina).</p></sec><sec id="S2-8"><title>Next-Generation Sequencing</title><p>Paired-end NGS (2&#x02009;&#x000d7;&#x02009;221&#x02009;bp) was performed on the MiSeq platform (Illumina, San Diego, CA, USA) with the use of an Illumina MiSeq Reagent Kit V3, according to the manufacturer&#x02019;s protocol (Illumina).</p></sec><sec id="S2-9"><title>Bioinformatic Data Analysis</title><p>Illumina NGS data were obtained in FASTQ format. Paired-end reads were combined using the FASTQ-join tool in the Erasmus MC Galaxy Server (<xref rid="B26" ref-type="bibr">26</xref>), with the use of <uri xlink:type="simple" xlink:href="http://usegalaxy.org">usegalaxy.org</uri> (<xref rid="B27" ref-type="bibr">27</xref>&#x02013;<xref rid="B29" ref-type="bibr">29</xref>) converted from FASTQ to FASTA with the converter tool (<xref rid="B30" ref-type="bibr">30</xref>). Sequencing annotations were made <italic>via</italic> the IMGT High V-quest database (<xref rid="B31" ref-type="bibr">31</xref>&#x02013;<xref rid="B34" ref-type="bibr">34</xref>). Calculation of the clonality score for multiple replicates was based on the algorithm described by Boyd et al. (<xref rid="B35" ref-type="bibr">35</xref>). Clonal type definition was based on V and J gene usage and CDR3-region at the nucleotide level. Rearrangements were visualized using Circoletto plots [<uri xlink:type="simple" xlink:href="http://www.circos.ca">www.circos.ca</uri> (<xref rid="B36" ref-type="bibr">36</xref>)]. CDR3 amino acid compositions were visualized using WebLogo online tool [<uri xlink:type="simple" xlink:href="http://www.weblogo.berkeley.edu">www.weblogo.berkeley.edu</uri> (<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B38" ref-type="bibr">38</xref>)].</p><p>The NGS TRG-TRD data set has been submitted to the BioProject repository (BioProjectID: PRJNA434217, submissionID SUB3660187; <uri xlink:type="simple" xlink:href="http://www.ncbi.nlm.nih.gov/bioproject/434217">http://www.ncbi.nlm.nih.gov/bioproject/434217</uri>). Sequencing details can be accessed through SRA database accession SRP133150 (<uri xlink:type="simple" xlink:href="https://www.ncbi.nlm.nih.gov/sra/SRP133150">https://www.ncbi.nlm.nih.gov/sra/SRP133150</uri>).</p></sec><sec id="S2-10"><title>Statistical Analysis</title><p>Data were checked for normal distributions using the Hartigan&#x02019;s Dip Test Statistic for Unimodality package (<xref rid="B39" ref-type="bibr">39</xref>&#x02013;<xref rid="B41" ref-type="bibr">41</xref>) in R version 3.4.1 (<xref rid="B42" ref-type="bibr">42</xref>). All statistical analyses were performed with Prism 5 (GraphPad, La Jolla, CA, USA).</p></sec></sec><sec id="S3"><title>Results</title><sec id="S3-1"><title>Multiplex PCR Assay Fine-Tuning Leads to an Optimized, Bias-Free NGS Assay for Reliable Quantification of the TRG/TRD Repertoire</title><p>The multiplex PCR assay to be analyzed by NGS was optimized and fine-tuned for more accurate quantification and receptor diversity analysis of the TRG and TRD loci using a diverse set of artificial DNA spike-in samples and primer concentration titration experiments (Tables S4 and S5 and Figures S2 and S3 in Supplementary Material). Each artificial DNA sample, represented by plasmid vector DNA, contained a mixture of known V(D)J rearrangements, cloned from either immature T-cell lines or thymus DNA in equimolar proportions (Table S4 in Supplementary Material). After several rounds of fine-tuning (Figures S2 and S3 in Supplementary Material), and repeated technical validation with plasmid spike-in pools we established the most optimal PCR conditions for both TRG (Figure <xref ref-type="fig" rid="F1">1</xref>A) and TRD (Figure <xref ref-type="fig" rid="F1">1</xref>B) multiplex assays in view of unbiased NGS data. Remaining small differences between observed and expected read frequencies are introduced by chance in the PCR reaction and/or due to inevitable interassay variation. These were reduced to a minimum by using four replicates for each sample, which included four differently pipetted mixes to reduce pipetting bias and the use of four different PCR machines to reduce machine-dependent bias. These optimization experiments resulted in variable primer concentrations and defined annealing temperatures and cycle numbers for the TRG and TRD multiplex PCR reactions (Table S5 in Supplementary Material).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Technical optimization of next-generation sequencing assays for TRG/TRD loci. Multiplex PCR assays were optimized with balanced primer concentrations, annealing temperatures, and cycle numbers as summarized in Table S3 in Supplementary Material. Plasmid pools were used as spike-in samples to determine the percentage expected sequences per V and J gene vs. the observed percentage after sequencing (Table S2 in Supplementary Material). Expected percentages are indicated in black bars, observed percentages are indicated in colored bars. TRG assays showed high overlap between frequencies of expected and observed sequences for V&#x003b3; and J&#x003b3; <bold>(A)</bold> genes, with some variation due to single primers covering multiple genes (V&#x003b3;1F covering V&#x003b3;2-8, J&#x003b3;1.1/2.1 covering J&#x003b3;1.1 and J&#x003b3;2.1, and J&#x003b3;1.3/2.3 covering J&#x003b3;1.3 and J&#x003b3;2.3). TRD assays showed nearly similar percentages of expected and observed sequences for V&#x003b4; and J&#x003b4; <bold>(B)</bold> genes. Error bars represent SD of PCR replicates (<italic>N</italic>&#x02009;=&#x02009;4).</p></caption><graphic xlink:href="fimmu-09-00448-g001"/></fig></sec><sec id="S3-2"><title>The TRG/TRD Repertoire Is Diverse in Immature Thymus and CB, and More Skewed in Mature Circulating TCR&#x003b3;&#x003b4;+ T-Cells</title><p>In order to determine changes in TCR&#x003b3;&#x003b4;+ T-cell repertoire in healthy individuals, we first investigated TRG/TRD repertoire diversity during ontogeny using purified TCR&#x003b3;&#x003b4;+ T-cells from different compartments, i.e., thymus (Thy) and neonatal CB. In addition, we sequenced the total mature TCR&#x003b3;&#x003b4;+ T-cell population of healthy adult PB samples. TRG rearrangements in Thy and CB samples were highly diverse (Figure <xref ref-type="fig" rid="F2">2</xref>A, upper two rows), and the intersample variation of especially Thy samples was low, in keeping with the non-selected character of the TCR&#x003b3;&#x003b4;+ T-cells in these compartments. These findings were in strong contrast to PB samples, which showed a high level of skewing and predominance of certain receptors (including V&#x003b3;9&#x02013;J&#x003b3;1.2 sequences) were observed (Figure <xref ref-type="fig" rid="F2">2</xref>A, bottom row), albeit with high inter-individual differences, illustrating the dominant role of (antigenic) selection. TRD diversity was less apparent, although in Thy and CB samples (Figure <xref ref-type="fig" rid="F2">2</xref>B, upper two rows) all three predominant V&#x003b4;-genes were identified. Again, intersample variation was low, illustrating the non-selected character of Thy and CB cells. Intersample variation was more evident for the PB samples (Figure <xref ref-type="fig" rid="F2">2</xref>B, bottom row), with predominance of V&#x003b4;2 usage, but also V&#x003b4;3 usage in some cases, reflecting different types of (antigenic) selection between individuals.</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>Circoletto visualization of the TRG/TRD repertoire during ontogeny. Optimized multiplex PCR next-generation sequencing assays were applied on total TCR&#x003b3;&#x003b4;+ T-cells sorted from thymus (Thy), neonatal cord blood (CB), and adult peripheral blood (PB). TRG assays showed high repertoire diversity in both Thy and CB samples, with low interindividual variation, while adult PB samples showed individual-specific repertoire patterns with less receptor diversity <bold>(A)</bold>. TRD assays showed high dominance of V&#x003b4;1 (light blue bars), which was also observed in CB samples, both with low intersample variation. Adult PB samples showed donor-specific patterns with sometimes skewing toward V&#x003b4;2 and even V&#x003b4;3 <bold>(B)</bold>. Three representative samples of each samples type are visualized: Thy04-10, Thy05-13, Thy10-03, CB2, CB3, CB4, PB30, PB31, and PB50. Plots were made using the Circoletto online software tool [<uri xlink:type="simple" xlink:href="http://www.circos.ca">http://www.circos.ca</uri> (<xref rid="B35" ref-type="bibr">35</xref>)]. Each band represents a V&#x02013;J rearrangement, with colors based on V-gene usage.</p></caption><graphic xlink:href="fimmu-09-00448-g002"/></fig><p>Collectively, these data confirmed our hypothesis of a broad and diverse TRG/TRD repertoire in the immature Thy and CB samples and a more skewed TRG/TRD repertoire in mature circulating TCR&#x003b3;&#x003b4;+ T-cells in adults, thereby validating our optimized multiplex PCR-based TRG/TRD NGS assays.</p></sec><sec id="S3-3"><title>Upon Aging Memory TCR&#x003b3;&#x003b4;+ T-Cells Show Shifts in V-Gene Usage, Whereas Naive and Effector Populations Do Not</title><p>As it has become evident that aging plays a major role in shaping the elderly immune system (<xref rid="B43" ref-type="bibr">43</xref>), we next evaluated the role of aging on the combinatorial TRG/TRD repertoire. To this end, we sorted TCR&#x003b3;&#x003b4;+ T-cells from healthy young (<italic>N</italic>&#x02009;=&#x02009;11; age range 20&#x02013;35) and elderly (<italic>N</italic>&#x02009;=&#x02009;12; age range 56&#x02013;70) individuals into four subsets: naive (CD45RA+ CD45RO&#x02212; CD27+ CD197+), central memory (CD45RA&#x02212; CD45RO+ CD27+ CD197+), effector memory (Temro; CD45RA&#x02212; CD45RO+ CD27&#x02212; CD197&#x02212;), and effector (Temra; CD45RA+ CD45RO&#x02212; CD27&#x02212; CD197&#x02212;) TCR&#x003b3;&#x003b4;+ T-cells. Subset distributions of young and elderly individuals (Figure S4 in Supplementary Material) correlated with those from our previous aging study, from which it is known that TCR&#x003b3;&#x003b4;+ T cells show little CCR7 expression fitting with low absolute and relative numbers of naive and central memory cells (<xref rid="B44" ref-type="bibr">44</xref>) (Table S6 in Supplementary Material). Even though the spectrum of V&#x02013;J combinations for both TRG and TRD varied in a donor-specific way between individuals (Figure S5 in Supplementary Material), the overall TRG/TRD combinatorial diversity appeared to be mostly determined by differences in V&#x003b3;/V&#x003b4; usage rather than J&#x003b3;/J&#x003b4; gene usage.</p><p>Naive TCR&#x003b3;&#x003b4;+ T-cells of both young and elderly individuals showed a relatively diverse TRG repertoire, which was in strong contrast to (central and effector) memory TCR&#x003b3;&#x003b4;+ T-cells that showed dominant V&#x003b3;9 gene usage. Effector TCR&#x003b3;&#x003b4;+ T-cells of both age groups were more diverse again. Of note, significant differences between young and elderly could be observed in mainly the memory populations, as reflected by a significantly higher V&#x003b3;2-usage in central memory TCR&#x003b3;&#x003b4;+ T-cells in elderly, as well as significantly lower V&#x003b3;2-8-usage and significantly higher V&#x003b3;9 gene usage in effector memory cells of elderly (Figure <xref ref-type="fig" rid="F3">3</xref>A).</p><fig id="F3" position="float"><label>Figure 3</label><caption><p>V gene diversity in the combinatorial TRG/TRD repertoire of different TCR&#x003b3;&#x003b4;+ T-cell subsets from young and elderly individuals. V-gene usage per subset visualized in bar graphs indicating a diverse repertoire in naive and effector subsets of both young and elderly, with skewing toward V&#x003b3;2 and V&#x003b3;9 in memory populations <bold>(A)</bold>. Naive populations showed diversity in V&#x003b4; usage with V&#x003b4;1 dominance in young and elderly. Young individuals showed relatively higher V&#x003b4;2 usage in especially the memory and effector subsets, whereas elderly individuals showed clear V&#x003b4;1 dominance in all subsets, except for effector memory cells <bold>(B)</bold>. Median V-gene frequencies of productive sequences with SD bars were indicated in bar graphs for young (<italic>N</italic>&#x02009;=&#x02009;11) and elderly (<italic>N</italic>&#x02009;=&#x02009;12) individuals. Color legends are indicated in the figure. Statistical significance was tested using the Mann&#x02013;Whitney <italic>U</italic>-test. Level of significance is indicated in the plots: *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05; **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01; ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.0001.</p></caption><graphic xlink:href="fimmu-09-00448-g003"/></fig><p>When comparing TRD combinatorial profiles in the different subsets between young and elderly individuals, significantly higher V&#x003b4;1 and significantly lower V&#x003b4;2 gene usage was observed in memory populations of elderly individuals. This effect was also observed in the effector population. In the effector memory cells of elderly V&#x003b4;3 gene usage was also significantly higher (Figure <xref ref-type="fig" rid="F3">3</xref>B).</p><p>Overall, these data show clear differences in the TRG/TRD combinatorial repertoire between naive TCR&#x003b3;&#x003b4;+ T-cells on the one hand and especially memory TCR&#x003b3;&#x003b4;+ T-cells on the other hand. Notably, the clear dominance of V&#x003b3;9 and V&#x003b4;2 usage in memory and effector TCR&#x003b3;&#x003b4;+ T-cells in young individuals was less prominent in elderly individuals, who on average showed significant shifts toward more V&#x003b3;2 and V&#x003b4;1 gene usage in addition to V&#x003b3;9 and V&#x003b4;2. Most significant differences between young and elderly were identified in central and effector memory populations.</p></sec><sec id="S3-4"><title>The TRG/TRD Junctional Region Repertoire Shows Signs of Selection in Memory and Effector Cell Populations of both Young and Old Individuals</title><p>For a more detailed view of the TRG/TRD repertoire, we then studied CDR3-regions, which reflect the most relevant antigen-binding part of the antigen receptors. These CDR3-length distributions are indicative of the junctional repertoire. TRG/TRD CDR3-length distributions of Thy TCR&#x003b3;&#x003b4;+ T-cells showed Gaussian profiles, just like the TRD CDR3-length distributions of CB TCR&#x003b3;&#x003b4;+ T-cells; TRG CDR3-lengths of CB TCR&#x003b3;&#x003b4;+ T-cells showed less clear Gaussian distributions and more prominent peaks, probably reflecting low-level selection (Figure S6 in Supplementary Material). The effect of selection became even more evident in adult individuals; naive TCR&#x003b3;&#x003b4;+ T-cells showed mostly Gaussian CDR3 profiles, in contrast to memory and effector TCR&#x003b3;&#x003b4;+ T-cells of young individuals, which showed dominant peaks for both the TRG and TRD CDR3-regions (Figures <xref ref-type="fig" rid="F4">4</xref>A,B). Elderly individuals did not show clear Gaussian profiles, and even prominent peaks in all subsets, thus reflecting a more heavily selected repertoire (Figures <xref ref-type="fig" rid="F4">4</xref>A,B). The average TRG and TRD CDR3-lengths were not markedly different between young and elderly individuals.</p><fig id="F4" position="float"><label>Figure 4</label><caption><p>CDR3-length distributions of TCR&#x003b3;&#x003b4;+ T-cell subsets from young and elderly individuals. Frequencies of CDR3-lengths from different TCR&#x003b3;&#x003b4;+ T-cell subsets are summarized per T-cell receptor chain and age group. Naive subsets (red lines) showed distributions resembling Gaussian profiles, while memory subsets showed dominant peaks suggestive of selection and receptor skewing (green and purple lines). TRG CDR3-lengths showed similar distributions between young and elderly <bold>(A)</bold>, TRD CDR3-lengths in young individuals showed a Gaussian profile in the naive subset and more skewing in memory and effector subsets, whereas in elderly individuals all subsets showed dominant peaks <bold>(B)</bold>. Mean frequencies per subset were indicated for young (<italic>N</italic>&#x02009;=&#x02009;11) and elderly (<italic>N</italic>&#x02009;=&#x02009;12) individuals. Data normality was tested using the diptest package in R.</p></caption><graphic xlink:href="fimmu-09-00448-g004"/></fig></sec><sec id="S3-5"><title>TRG Canonical and TRD Invariant T Selection Determinants are Detectable in Normal TCR&#x003b3;&#x003b4;+ T-Cells but Do Not Increase upon Aging</title><p>During development selection of TCR&#x003b3;&#x003b4;+ T-cells is known to be associated with so-called selection determinants, which represent molecular fingerprints in the CDR3-regions of TRG and TRD chains. In circulating TCR&#x003b3;&#x003b4;+ T-cells a high frequency of V&#x003b3;9&#x02013;J&#x003b3;1.2 recombinations with preferential joining at the GCA sequence has been noted (Figure <xref ref-type="fig" rid="F5">5</xref>A). We therefore studied this so-called canonical V&#x003b3;9&#x02013;J&#x003b3;1.2 rearrangement, characterized by a defined CDR3-length and amino acid composition (Figure <xref ref-type="fig" rid="F5">5</xref>A), in different subsets of young and elderly healthy controls. Approximately 10&#x02013;20% of all productive V&#x003b3;9&#x02013;J&#x003b3;1.2 rearrangements contained the canonical sequence (Figure <xref ref-type="fig" rid="F5">5</xref>B). The frequencies of canonical V&#x003b3;9&#x02013;J&#x003b3;1.2 sequences did not clearly differ between different subsets in young and elderly (Figure <xref ref-type="fig" rid="F5">5</xref>B). In TCR&#x003b3;&#x003b4;-receptors the canonical V&#x003b3;9&#x02013;J&#x003b3;1.2 chain is frequently combined with a V&#x003b4;2-derived chain, especially resulting from V&#x003b4;2&#x02013;J&#x003b4;1 recombination. These V&#x003b4;2&#x02013;J&#x003b4;1 rearrangements often contain a so-called invariant T nucleotide, a selection determinant at the relative second position of the first codon of the junctional region (Figure <xref ref-type="fig" rid="F5">5</xref>C), translating into leucine (L), valine (V), or isoleucine (I) amino acids at that first codon in the junction. The invariant T was observed in all individuals (Figure <xref ref-type="fig" rid="F5">5</xref>D, outer gray circles), and resulted in L, V or I amino acids at this position (Figure <xref ref-type="fig" rid="F5">5</xref>D, inner blue pie charts). The invariant T was present at higher frequency in memory and effector subsets compared to naive TCR&#x003b3;&#x003b4;+ T-cell subsets. On average, invariant T frequencies per subset did not differ much between young and elderly individuals, although the percentage of invariant T-containing sequences at the nucleotide level of naive TCR&#x003b3;&#x003b4;+ T-cells of young individuals was clearly lower than that of elderly naive TCR&#x003b3;&#x003b4;+ T-cells (Figure <xref ref-type="fig" rid="F5">5</xref>D).</p><fig id="F5" position="float"><label>Figure 5</label><caption><p>Canonical V&#x003b3;9&#x02013;J&#x003b3;1.2 sequences and V&#x003b4;2&#x02013;J&#x003b4;1 invariant T selection determinant in young and elderly healthy individuals. GCA sequence in bold mediates preferential recombination of V&#x003b3;9 with J&#x003b3;1.2, resulting in specific CDR3 length and amino acid composition, adapted from Ref. (<xref rid="B45" ref-type="bibr">45</xref>) <bold>(A)</bold>. Frequencies of all productive V&#x003b3;9&#x02013;J&#x003b3;1.2 sequences containing the canonical sequence per age group and subset marked in dark gray. In light gray V&#x003b3;9&#x02013;J&#x003b3;1.2 rearrangements with other, non-canonical sequences are indicated. Numbers of total V&#x003b3;9&#x02013;J&#x003b3;1.2 sequences are indicated in center of plots <bold>(B)</bold>. The invariant T selection determinant is located at the relative second position of the first codon in the junction of V&#x003b4;2&#x02013;J&#x003b4;1 rearrangements, adapted from Ref. (<xref rid="B13" ref-type="bibr">13</xref>) <bold>(C)</bold>. Frequencies of invariant T selection determinant in young and elderly subsets (dark gray part outer ring), leading to L, V, or I amino acid residues (inner blue pie chart, dark blue part). Absolute number of unique productive V&#x003b4;2&#x02013;J&#x003b4;1 sequences indicated next to plots <bold>(D)</bold>.</p></caption><graphic xlink:href="fimmu-09-00448-g005"/></fig><p>Taken together, the most common selection determinants described in TCR&#x003b3;&#x003b4;+ T-cells (i.e., the V&#x003b3;9&#x02013;J&#x003b3;1.2 canonical sequence and the V&#x003b4;2&#x02013;J&#x003b4;1 invariant T nucleotide) were readily identified in different TCR&#x003b3;&#x003b4;+ T-cell subsets in our healthy control cohort, albeit that frequencies did not clearly differ between young and elderly.</p></sec><sec id="S3-6"><title>Analysis of TRG/TRD Clonotypes Shows the Presence of TCR&#x003b3;&#x003b4;+ T-LGL Leukemia-Related Clonotypes in Especially Effector Cells of Elderly</title><p>In view of TCR&#x003b3;&#x003b4;+ T-cell selection processes, we then studied the possible recurrence of specific TRG/TRD clonotypes in the repertoire of young and elderly individuals, as a sign of activated TCR&#x003b3;&#x003b4;+ T-cell clones. To this end multiple replicates (<italic>N</italic>&#x02009;=&#x02009;3) of each TCR&#x003b3;&#x003b4;+ T-cell subset were studied in independent PCR reactions and the number of so-called coincident sequences was determined (<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B46" ref-type="bibr">46</xref>). In all subsets, both young and elderly, the frequency of clonotype sequences found in only one of the replicates was the highest, while the frequencies of coincidences found in two or three replicates were relatively low for both TRG and TRD (Figure S7 in Supplementary Material). When comparing young and elderly, small shifts leading to higher numbers of coincidences in two or three replicates were seen in the latter (Figure S7 in Supplementary Material). We then only focused on the coincidences present in all three replicates, since these sequences best reflect the individuals&#x02019; repertoire selection. Especially in the effector memory population absolute numbers of sequences found in all three replicates were higher, while in naive subsets from both young and elderly these numbers were lower, except for a few cases (Table S7 in Supplementary Material).</p><p>To understand whether the recurrence of clonotypes would be associated with particular infections, we next evaluated receptor clonotypes linked to pathogens such as <italic>M. tuberculosis</italic> (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B47" ref-type="bibr">47</xref>) and herpes viruses such as CMV (<xref rid="B18" ref-type="bibr">18</xref>). Whereas in our healthy controls no <italic>M. tuberculosis</italic>-specific clonotypes could be identified, CMV-specific TRG or TRD clonotypes were found in most controls, and in one case even a complete CMV-specific TCR&#x003b3;&#x003b4; receptor could be identified (data not shown). However, there were no evident differences between young and elderly individuals.</p><p>Finally, as leukemic TCR&#x003b3;&#x003b4;+ T-cells typically arise in the elderly population and are associated with specific clonotypes, we retrospectively reviewed our TCR&#x003b3;&#x003b4;+ T-cell LGL leukemia database of clonal TRG/TRD sequences (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B47" ref-type="bibr">47</xref>) and searched for these LGL clonotypes in the normal TCR&#x003b3;&#x003b4;+ T-cell repertoire of young and elderly healthy individuals. Interestingly, two TCR&#x003b3;&#x003b4;+ T-LGL leukemia-associated TRG and TRD clonotypes were found in four older individuals and in one young individual (Table <xref ref-type="table" rid="T1">1</xref>). The V&#x003b4;3&#x02013;J&#x003b4;1 receptor as identified in TCR&#x003b3;&#x003b4;+ T-LGL leukemia case 12-098 was identified in one young individual (naive subset, 26-year-old female), and in three older individuals (naive subset, 56-year-old male; effector subset, 69-year-old female and 68-year-old male) (Table <xref ref-type="table" rid="T1">1</xref>). The TCR&#x003b3;&#x003b4;+ T-LGL leukemia-related receptor from case 10 to 200 was found twice in older individuals (naive subset, 56-year-old male; effector subset, 70-year-old male) (Table <xref ref-type="table" rid="T1">1</xref>). Although the numbers are low, the fact that two TCR&#x003b3;&#x003b4;+ T-LGL leukemia-related receptors could specifically be identified in effector cells of elderly would support the idea that TCR&#x003b3;&#x003b4;+ T-LGL leukemia cells originate from the normal TCR&#x003b3;&#x003b4; repertoire, especially from antigen-experienced TCR&#x003b3;&#x003b4;+ T-cells of individuals of older age (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B49" ref-type="bibr">49</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Complete TCR&#x003b3;&#x003b4;+ T-LGL leukemia receptor clonotypes identified in the repertoire of healthy young and elderly individuals.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" colspan="4" rowspan="1">Sample information<hr/></th><th valign="top" align="center" rowspan="2" colspan="1">LGL sample</th><th valign="top" align="center" colspan="2" rowspan="1">TRG receptor chain<hr/></th><th valign="top" align="center" colspan="2" rowspan="1">TRD receptor chain<hr/></th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1">Donor</th><th valign="top" align="center" rowspan="1" colspan="1">Sex</th><th valign="top" align="center" rowspan="1" colspan="1">Age</th><th valign="top" align="left" rowspan="1" colspan="1">Subset</th><th valign="top" align="center" rowspan="1" colspan="1">V-J rearrangement</th><th valign="top" align="left" rowspan="1" colspan="1">CDR3 composition</th><th valign="top" align="center" rowspan="1" colspan="1">V-J rearrangement</th><th valign="top" align="left" rowspan="1" colspan="1">CDR3 composition</th></tr></thead><tbody><tr><td align="left" valign="top" colspan="9" rowspan="1"><bold>Young individuals</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">B49</td><td align="center" valign="top" rowspan="1" colspan="1">F</td><td align="center" valign="top" rowspan="1" colspan="1">26</td><td align="left" valign="top" rowspan="1" colspan="1">Naive</td><td align="center" valign="top" rowspan="1" colspan="1">LGL 12-098</td><td align="center" valign="top" rowspan="1" colspan="1">V&#x003b4;3&#x02013;J&#x003b4;1</td><td align="left" valign="top" rowspan="1" colspan="1">CAFSSLTGGYKEYTDKLIF</td><td align="center" valign="top" rowspan="1" colspan="1">V&#x003b3;9&#x02013;J&#x003b3;1.3</td><td align="left" valign="top" rowspan="1" colspan="1">CALWEVPNYKKLF</td></tr><tr><td align="left" valign="top" colspan="9" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" colspan="9" rowspan="1"><bold>Elderly individuals</bold></td></tr><tr><td align="left" valign="top" rowspan="2" colspan="1">B41</td><td align="center" valign="top" rowspan="2" colspan="1">M</td><td align="center" valign="top" rowspan="2" colspan="1">56</td><td align="left" valign="top" rowspan="2" colspan="1">Naive</td><td align="center" valign="top" rowspan="1" colspan="1">LGL 10-200</td><td align="center" valign="top" rowspan="1" colspan="1">V&#x003b4;2&#x02013;J&#x003b4;1</td><td align="left" valign="top" rowspan="1" colspan="1">CACDTVGDRDTDKLIF</td><td align="center" valign="top" rowspan="1" colspan="1">V&#x003b3;9&#x02013;J&#x003b3;1.3</td><td align="left" valign="top" rowspan="1" colspan="1">CALWEVQYYKKLF</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">LGL 12-098</td><td align="center" valign="top" rowspan="1" colspan="1">V&#x003b4;3&#x02013;J&#x003b4;1</td><td align="left" valign="top" rowspan="1" colspan="1">CAFSSLTGGYKEYTDKLIF</td><td align="center" valign="top" rowspan="1" colspan="1">V&#x003b3;9&#x02013;J&#x003b3;1.3</td><td align="left" valign="top" rowspan="1" colspan="1">CALWEVPNYKKLF</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">B51</td><td align="center" valign="top" rowspan="1" colspan="1">M</td><td align="center" valign="top" rowspan="1" colspan="1">70</td><td align="left" valign="top" rowspan="1" colspan="1">Effector</td><td align="center" valign="top" rowspan="1" colspan="1">LGL 10-200</td><td align="center" valign="top" rowspan="1" colspan="1">V&#x003b4;2&#x02013;J&#x003b4;1</td><td align="left" valign="top" rowspan="1" colspan="1">CACDTVGDRDTDKLIF</td><td align="center" valign="top" rowspan="1" colspan="1">V&#x003b3;9&#x02013;J&#x003b3;1.3</td><td align="left" valign="top" rowspan="1" colspan="1">CALWEVQYYKKLF</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">B44</td><td align="center" valign="top" rowspan="1" colspan="1">F</td><td align="center" valign="top" rowspan="1" colspan="1">69</td><td align="left" valign="top" rowspan="1" colspan="1">Effector</td><td align="center" valign="top" rowspan="1" colspan="1">LGL 12-098</td><td align="center" valign="top" rowspan="1" colspan="1">V&#x003b4;3&#x02013;J&#x003b4;1</td><td align="left" valign="top" rowspan="1" colspan="1">CAFSSLTGGYKEYTDKLIF</td><td align="center" valign="top" rowspan="1" colspan="1">V&#x003b3;9&#x02013;J&#x003b3;1.3</td><td align="left" valign="top" rowspan="1" colspan="1">CALWEVPNYKKLF</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">B60</td><td align="center" valign="top" rowspan="1" colspan="1">M</td><td align="center" valign="top" rowspan="1" colspan="1">68</td><td align="left" valign="top" rowspan="1" colspan="1">Effector</td><td align="center" valign="top" rowspan="1" colspan="1">LGL 12-098</td><td align="center" valign="top" rowspan="1" colspan="1">V&#x003b4;3&#x02013;J&#x003b4;1</td><td align="left" valign="top" rowspan="1" colspan="1">CAFSSLTGGYKEYTDKLIF</td><td align="center" valign="top" rowspan="1" colspan="1">V&#x003b3;9&#x02013;J&#x003b3;1.3</td><td align="left" valign="top" rowspan="1" colspan="1">CALWEVPNYKKLF</td></tr></tbody></table></table-wrap></sec></sec><sec sec-type="discussion" id="S4"><title>Discussion</title><p>Aging of the immune system has become increasingly important due to increased hygiene and higher life expectancies in the Western World (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B50" ref-type="bibr">50</xref>). Immunosenescence plays an additional role in shaping the immune repertoire. Shaping of the immune system during ontogeny and upon aging relies on continuous antigenic exposures, varying from pathogens to cellular stress. In the current study, we showed that (antigenic) selection starts during early ontogeny in the thymus and CB samples and continues in circulating TCR&#x003b3;&#x003b4;+ T-cells in young and elderly individuals. While maintaining diversity in the naive subsets, the effect of aging is most significant in memory subsets, characterized by strong receptor skewing, and in effector subsets.</p><p>Following technical optimization of multiplex PCR assays for NGS analysis, we demonstrated highly diverse TRG, but V&#x003b4;1-skewed TCR&#x003b3;&#x003b4;+ T-cell repertoires in precursor TCR&#x003b3;&#x003b4;+ T-cells from thymus and CB, with low inter-sample variation. This was in clear contrast to circulating mature TCR&#x003b3;&#x003b4;+ T-cells that showed V&#x003b3;9/V&#x003b4;2 receptor skewing with high inter-sample variation and donor-specific patterns. As we recently showed significant effects of aging on maturation profiles of TCR&#x003b3;&#x003b4;+ T-cells (<xref rid="B49" ref-type="bibr">49</xref>), we investigated the immune repertoire composition of different TCR&#x003b3;&#x003b4;+ T-cell subsets including naive, central, and effector memory, and effector cells. Even though the naive TCR&#x003b3;&#x003b4;+ T-cell population shrinks upon aging (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B49" ref-type="bibr">49</xref>), its diversity&#x02014;being the primary source for mounting immune responses&#x02014;was maintained in elderly individuals. To date, only one study documented the maintenance of the naive CD4+ TCR&#x003b1;&#x003b2;+ T-cell repertoire until the age of 70, after which the repertoire profoundly declined (<xref rid="B51" ref-type="bibr">51</xref>) [reviewed in Ref. (<xref rid="B52" ref-type="bibr">52</xref>)]. These results are in line with our findings, although our cohort consisted of elderly until the age of 70. This is one drawback of our study, but the maximum age to donate blood at our national blood bank is 70. Nevertheless, it would be interesting to also study healthy individuals &#x0003e;70&#x02009;years of age, although the high volumes of blood needed to obtain sufficient numbers of naiveTCR&#x003b3;&#x003b4;+ T-cells could complicate such studies. Low cell numbers pose serious limitations to studying the repertoire due to potentially low levels of input DNA and skewed data. To overcome such limitations and to directly link overall receptor usage for both TRG and TRD loci, single molecule-based assays could be considered. However, these assays are rather novel and require extensive optimization and validation experiments as well. Another limitation of our study is the fact that due to limited cell material, we could not go into mechanistic and functional implications of our findings.</p><p>Age-related differences were most evident in central and effector memory populations: V&#x003b3;9 usage was highly important in young individuals, while a shift toward V&#x003b3;2 and other V&#x003b3;1-family genes was observed in effector memory TCR&#x003b3;&#x003b4;+ T-cells of elderly. The significant increase in V&#x003b3;2 usage in elderly was accompanied by a significant decrease in V&#x003b4;2 and increase in V&#x003b4;1 usage, collectively indicating a shift from V&#x003b3;9/V&#x003b4;2 specificity in young to V&#x003b3;2/V&#x003b4;1 in elderly. These findings might suggest differences in antigenic selection, or might be due to underlying clonal expansion in these populations (<xref rid="B53" ref-type="bibr">53</xref>). Also, CMV is known to elicit V&#x003b4;1+ TCR&#x003b3;&#x003b4;+ T-cell-specific responses (<xref rid="B17" ref-type="bibr">17</xref>). Additionally, we have recently demonstrated the effect of CMV on the TCR&#x003b3;&#x003b4;+ T-cell immune system, through increasing V&#x003b4;1+ TCR&#x003b3;&#x003b4;+ T-cells in elderly carrying CMV (<xref rid="B49" ref-type="bibr">49</xref>), and it has been shown that latent CMV carriage is related to the expansion of CMV specific T-cells (<xref rid="B54" ref-type="bibr">54</xref>). When zooming in on the antigen-binding part, the CDR3 region, we could indeed identify CMV-specific CDR3 regions in a few donors, albeit without a significant aging effect. This could reflect high anti-CMV responses mounted by V&#x003b4;1+ TCR&#x003b3;&#x003b4;+ T-cells, although such responses were mainly observed in renal allograft recipients and not in healthy controls (<xref rid="B17" ref-type="bibr">17</xref>). Given that CMV infects mainly fibroblasts and epithelial cells (<xref rid="B55" ref-type="bibr">55</xref>), and that the majority of V&#x003b4;1+ TCR&#x003b3;&#x003b4;+ T-cells reside in epithelial and mucosal tissues (<xref rid="B56" ref-type="bibr">56</xref>&#x02013;<xref rid="B58" ref-type="bibr">58</xref>) these findings could indicate that healthy individuals have a local, rather than circulatory, protection by V&#x003b4;1+ TCR&#x003b3;&#x003b4;+ T-cells against CMV. Interestingly, in a recent study Davey et al., showed that the V&#x003b4;1 population in CB is unfocused, but that in adult PB clonal expansions could be found that had directly differentiated from naive into effector phenotypes with parallel CD27 downregulation (<xref rid="B59" ref-type="bibr">59</xref>). In contrast, V&#x003b4;2 cells maintained their TCR expression from birth to adulthood. Together with the CMV effect upon aging, these findings could explain the higher V&#x003b4;1 usage in elderly and possibly the occurrence of clonopathies.</p><p>In this study, we also examined other dominant TRG/TRD clonotypes, such as for <italic>M. tuberculosis</italic>, since TCR&#x003b3;&#x003b4;+ T-cells are known to elicit strong responses (<xref rid="B16" ref-type="bibr">16</xref>), but these were not identified. This could be related to the recruitment of our donors (mostly of Caucasian descent) <italic>via</italic> the national Dutch blood bank, and the fact that donors are tested prior to blood donation. Furthermore, open tuberculosis is not endemic in the Netherlands. Curiously, some TRG/TRD clonotypes derived from complete TCR&#x003b3;&#x003b4;+ T-LGL leukemia receptors were identified in the healthy effector subset repertoire. These findings would be in line with earlier correlations identified between TCR&#x003b3;&#x003b4;+ T-LGL leukemia cells and healthy effector TCR&#x003b3;&#x003b4;+ T-cells (<xref rid="B49" ref-type="bibr">49</xref>) and would support the concept that TCR&#x003b3;&#x003b4;+ T-LGL is a disease that typically arises in effector cells of elderly.</p><p>Our optimized multiplex PCR assays for NGS analysis could also be applicable to other disease states, such as TCR&#x003b3;&#x003b4;+ T-cell lymphomas, or treatments, such as bone marrow transplantation (BMTx). TCR&#x003b3;&#x003b4;+ T-cells have been described to reconstitute in increased numbers after BMTx in acute leukemia patients (<xref rid="B60" ref-type="bibr">60</xref>). The here described method would allow to investigate to what extent the TRG/TRD repertoire has changed upon BMTx, and how the TCR&#x003b3;&#x003b4;+ T-cell compartment regenerates. Also, circulating TCR&#x003b3;&#x003b4;+ T-cells have been described in metastatic melanomas, in which it would be interesting to distinguish pro- and anti-tumor specific TCR&#x003b3;&#x003b4;+ T-cells (<xref rid="B61" ref-type="bibr">61</xref>), the latter particularly in view of tumor-eradicating effects (<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B62" ref-type="bibr">62</xref>). Also, investigating the TRG/TRD repertoires of tissue-residing TCR&#x003b3;&#x003b4;+ T-cells could be relevant, not only for CMV-specific responses, but also for other local antigens contributing to the TCR&#x003b3;&#x003b4;+ T-cell repertoire. As the ability of TCR&#x003b3;&#x003b4;+ T-cells to move in and out of tissues has not been convincingly demonstrated yet, sequencing TCR&#x003b3;&#x003b4;+ T-cells from different tissues could provide insight in both residing, migrating and circulating properties, as well as in development of local immune repertoires and additional functions and specificities of TCR&#x003b3;&#x003b4;+ T-cells.</p><p>In summary, using an optimized NGS assay we identified specific TRG/TRD repertoires during ontogeny and upon aging. Despite strong individual-specific repertoire compositions, significant differences in V&#x003b3; and V&#x003b4; gene usage were identified upon aging in especially the memory TCR&#x003b3;&#x003b4;+ T-cell subsets. These age-dependent effects caused shifts from V&#x003b3;9/V&#x003b4;2 dominance in young to V&#x003b3;2/V&#x003b4;1 dominance in elderly. Additionally, some TRG/TRD clonotypes related to TCR&#x003b3;&#x003b4;+ T-LGL leukemia were identified in normal effector TCR&#x003b3;&#x003b4;+ T-cells of especially elderly individuals, which fits the idea that TCR&#x003b3;&#x003b4;+ T-LGL leukemia originates from normal circulating, antigen-experienced effector TCR&#x003b3;&#x003b4;+ T-cells.</p></sec><sec id="S5"><title>Ethics Statement</title><p>Blood from healthy blood donors from Sanquin Blood Bank (Amsterdam, The Netherlands) in the age ranges 20&#x02013;35 (young adults) and 56&#x02013;70 (elderly) was used upon informed consent (project number NVT0012.01) and anonymized for further use. Healthy neonatal CB was obtained postpartum or after Caesarian section upon informed consent through collaboration with the departments of Obstetrics and Hematology. Thymic lobes were removed upon heart surgery in individuals under the age of 2&#x02009;years. Both CB and thymus material was obtained under Medical Ethics Committee approval (project number hmPOO2004-003). All studies were conducted in accordance with the principles of the Declaration of Helsinki.</p></sec><sec id="S6"><title>Author Contributions</title><p>MJK, JD, and AL designed the experiments. MJK and AL wrote the manuscript. MJK, FK, MYK, and IW-T performed the experiments. MJK and AL analyzed the data and prepared the figures. PV, JD, and AL supervised the project. FK and PV revised the manuscript. All authors read the manuscript carefully.</p></sec><sec id="S7"><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>We are grateful to Mr. S. J. W. Bartol and Mrs. H. Charif-Bouallouch for help with cell sorting experiments and to Mr. A. Eggink for organizing cord blood samples. The research for this manuscript was performed within the framework of the Erasmus Postgraduate School Molecular Medicine.</p></ack><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> The study was performed <italic>via</italic> an unrestricted grant from Roche (to AL), which has no influence on the contents or publication of this research.</p></fn></fn-group><sec id="S8" sec-type="supplementary-material"><title>Supplementary Material</title><p>The Supplementary Material for this article can be found online at <uri xlink:type="simple" xlink:href="http://www.frontiersin.org/articles/10.3389/fimmu.2018.00448/full#supplementary-material">http://www.frontiersin.org/articles/10.3389/fimmu.2018.00448/full#supplementary-material</uri>.</p><supplementary-material content-type="local-data" id="SM1"><media xlink:href="data_sheet_1.PDF"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wherry</surname><given-names>EJ</given-names></name></person-group>
<article-title>T-cell exhaustion</article-title>. <source>Nat Immunol</source> (<year>2011</year>) <volume>12</volume>(<issue>6</issue>):<fpage>492</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/ni.2035</pub-id><pub-id pub-id-type="pmid">21739672</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wherry</surname><given-names>EJ</given-names></name><name><surname>Kurachi</surname><given-names>M</given-names></name></person-group>
<article-title>Molecular and cellular insights into T-cell exhaustion</article-title>. <source>Nat Rev Immunol</source> (<year>2015</year>) <volume>15</volume>(<issue>8</issue>):<fpage>486</fpage>&#x02013;<lpage>99</lpage>.<pub-id pub-id-type="doi">10.1038/nri/3862</pub-id><pub-id pub-id-type="pmid">26205583</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boraschi</surname><given-names>D</given-names></name><name><surname>Aguado</surname><given-names>MT</given-names></name><name><surname>Dutel</surname><given-names>C</given-names></name><name><surname>Goronzy</surname><given-names>J</given-names></name><name><surname>Louis</surname><given-names>J</given-names></name><name><surname>Grubeck-Loebenstein</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>The gracefully aging immune system</article-title>. <source>Sci Transl Med</source> (<year>2013</year>) <volume>5</volume>(<issue>185</issue>):<fpage>185s8</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.3005624</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aspinall</surname><given-names>R</given-names></name><name><surname>Andrew</surname><given-names>P</given-names></name></person-group>
<article-title>Thymic involution in aging</article-title>. <source>J Clin Immunol</source> (<year>2000</year>) <volume>20</volume>(<issue>4</issue>):<fpage>250</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1023/A:1006611518223</pub-id><pub-id pub-id-type="pmid">10939712</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiskopf</surname><given-names>D</given-names></name><name><surname>Weinberger</surname><given-names>B</given-names></name><name><surname>Grubeck-Loebenstein</surname><given-names>B</given-names></name></person-group>. <article-title>The aging of the immune system</article-title>. <source>Transpl Int</source> (<year>2009</year>) <volume>22</volume>:<fpage>1041</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1111/j.1432-2277.2009.00927.x</pub-id><?supplied-pmid 19624493?><pub-id pub-id-type="pmid">19624493</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>BI</given-names></name><name><surname>Akbar</surname><given-names>AN</given-names></name></person-group>. <article-title>Convergence of innate and adaptive immunity during human aging</article-title>. <source>Front Immunol</source> (<year>2016</year>) <volume>7</volume>:<fpage>445</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2016.00445</pub-id><?supplied-pmid 27867379?><pub-id pub-id-type="pmid">27867379</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oettinger</surname><given-names>MA</given-names></name><name><surname>Schatz</surname><given-names>DG</given-names></name><name><surname>Gorka</surname><given-names>C</given-names></name><name><surname>Baltimore</surname><given-names>D</given-names></name></person-group>. <article-title>RAG-1 and RAG-2 adjacent genes that synergistically activate V(D)J recombination</article-title>. <source>Science</source> (<year>1990</year>) <volume>248</volume>(<issue>4962</issue>):<fpage>1517</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1126/science.2360047</pub-id><?supplied-pmid 2360047?><pub-id pub-id-type="pmid">2360047</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dik</surname><given-names>WA</given-names></name><name><surname>Pike-Overzet</surname><given-names>K</given-names></name><name><surname>Weerkamp</surname><given-names>F</given-names></name><name><surname>de Ridder</surname><given-names>D</given-names></name><name><surname>de Haas</surname><given-names>EF</given-names></name><name><surname>Baert</surname><given-names>MR</given-names></name><etal/></person-group>
<article-title>New insights on human T-cell development by quantitative T-cell receptor gene rearrangement studies and gene expression profiling</article-title>. <source>J Exp Med</source> (<year>2005</year>) <volume>201</volume>(<issue>11</issue>):<fpage>1715</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20042524</pub-id><pub-id pub-id-type="pmid">15928199</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>G</given-names></name><name><surname>Rybakin</surname><given-names>V</given-names></name><name><surname>Brzostek</surname><given-names>J</given-names></name><name><surname>Paster</surname><given-names>W</given-names></name><name><surname>Acuto</surname><given-names>O</given-names></name><name><surname>Gascoigne</surname><given-names>NRJ</given-names></name></person-group>
<article-title>Fine-tuning T-cell receptor signaling to control T-cell development</article-title>. <source>Trends Immunol</source> (<year>2014</year>) <volume>35</volume>(<issue>7</issue>):<fpage>311</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.it.2014.05.003</pub-id><pub-id pub-id-type="pmid">24951034</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Dongen</surname><given-names>JJM</given-names></name><name><surname>Comans-Bitter</surname><given-names>WM</given-names></name><name><surname>Wolvers-Tettero</surname><given-names>ILM</given-names></name><name><surname>Borst</surname><given-names>J</given-names></name></person-group>
<article-title>Development of human T lymphocytes and their thymus-dependency</article-title>. <source>Thymus</source> (<year>1990</year>) <volume>16</volume>(<issue>3&#x02013;4</issue>):<fpage>207</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="pmid">2293424</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>CM</given-names></name><name><surname>Groh</surname><given-names>V</given-names></name><name><surname>Band</surname><given-names>H</given-names></name><name><surname>Porcelli</surname><given-names>SA</given-names></name><name><surname>Morita</surname><given-names>C</given-names></name><name><surname>Fabbi</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Evidence for extrathymic changes in the T-cell receptor gamma/delta repertoire</article-title>. <source>J Exp Med</source> (<year>1990</year>) <volume>171</volume>(<issue>5</issue>):<fpage>1597</fpage>&#x02013;<lpage>612</lpage>.<pub-id pub-id-type="doi">10.1084/jem.171.5.1597</pub-id><pub-id pub-id-type="pmid">2185330</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prinz</surname><given-names>I</given-names></name><name><surname>Silva-Santos</surname><given-names>B</given-names></name><name><surname>Pennington</surname><given-names>DJ</given-names></name></person-group>
<article-title>Functional development of &#x003b3;&#x003b4; T-cells</article-title>. <source>Eur J Immunol</source> (<year>2013</year>) <volume>43</volume>(<issue>8</issue>):<fpage>1988</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201343759</pub-id><pub-id pub-id-type="pmid">23928962</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandberg</surname><given-names>Y</given-names></name><name><surname>Almeida</surname><given-names>J</given-names></name><name><surname>Gonzalez</surname><given-names>M</given-names></name><name><surname>Lima</surname><given-names>M</given-names></name><name><surname>B&#x000e1;rcena</surname><given-names>P</given-names></name><name><surname>Szczepanski</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>TCR&#x003b3;&#x003b4;+ large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCR&#x003b3;&#x003b4;+ T-cells</article-title>. <source>Leukemia</source> (<year>2006</year>) <volume>20</volume>:<fpage>505</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="doi">10.1038/sj.leu.2404112</pub-id><pub-id pub-id-type="pmid">16437145</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davodeau</surname><given-names>F</given-names></name><name><surname>Peyrat</surname><given-names>MA</given-names></name><name><surname>Hallet</surname><given-names>MM</given-names></name><name><surname>Houde</surname><given-names>I</given-names></name><name><surname>Vie</surname><given-names>H</given-names></name><name><surname>Bonneville</surname><given-names>M</given-names></name></person-group>
<article-title>Peripheral selection of antigen receptor junctional features in a major human &#x003b3;&#x003b4; subset</article-title>. <source>Eur J Immunol</source> (<year>1993</year>) <volume>23</volume>:<fpage>804</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1002/eji.1830230405</pub-id><pub-id pub-id-type="pmid">8384559</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breit</surname><given-names>TM</given-names></name><name><surname>Wolvers-Tettero</surname><given-names>ILM</given-names></name><name><surname>van Dongen</surname><given-names>JJM</given-names></name></person-group>
<article-title>Unique selection determinant in polyclonal V&#x003b4;2 &#x02013; J&#x003b4;1 junctional regions of human peripheral &#x003b3;&#x003b4; T lymphocytes</article-title>. <source>J Immunol</source> (<year>1994</year>) <volume>152</volume>:<fpage>2860</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">7511631</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xi</surname><given-names>X</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name></person-group>
<article-title>Gammadelta T-cells response to <italic>Mycobacterium tuberculosis</italic> in pulmonary tuberculosis patients using preponderant complementary determinant region 3 sequence</article-title>. <source>Indian J Med Res</source> (<year>2011</year>) <volume>134</volume>:<fpage>356</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="pmid">21985819</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x000e9;chanet</surname><given-names>J</given-names></name><name><surname>Merville</surname><given-names>P</given-names></name><name><surname>Lim</surname><given-names>A</given-names></name><name><surname>Reti&#x000e8;re</surname><given-names>C</given-names></name><name><surname>Pitard</surname><given-names>V</given-names></name><name><surname>Lafarge</surname><given-names>X</given-names></name><etal/></person-group>
<article-title>Implication of &#x003b3;&#x003b4; T-cells in the human immune response to cytomegalovirus</article-title>. <source>J Clin Invest</source> (<year>1999</year>) <volume>103</volume>:<fpage>1437</fpage>&#x02013;<lpage>49</lpage>.<pub-id pub-id-type="doi">10.1172/JCI5409</pub-id><pub-id pub-id-type="pmid">10330426</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vermijlen</surname><given-names>D</given-names></name><name><surname>Brouwer</surname><given-names>M</given-names></name><name><surname>Donner</surname><given-names>C</given-names></name><name><surname>Liesnard</surname><given-names>C</given-names></name><name><surname>Tackoen</surname><given-names>M</given-names></name><name><surname>van Rysselberge</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Human cytomegalovirus elicits fetal &#x003b3;&#x003b4; T-cell responses in utero</article-title>. <source>J Exp Med</source> (<year>2010</year>) <volume>207</volume>(<issue>4</issue>):<fpage>807</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20090348</pub-id><pub-id pub-id-type="pmid">20368575</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujishima</surname><given-names>N</given-names></name><name><surname>Hirokawa</surname><given-names>M</given-names></name><name><surname>Fujishima</surname><given-names>M</given-names></name><name><surname>Yamashita</surname><given-names>J</given-names></name><name><surname>Saitoh</surname><given-names>H</given-names></name><name><surname>Ichikawa</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Skewed T-cell receptor repertoire of V&#x003b4;1+ &#x003b3;&#x003b4; T lymphocytes after human allogeneic haematopoietic stem cell transplantation and the potential role for Epstein-Barr virus-infected B cells in clonal restriction</article-title>. <source>Clin Exp Immunol</source> (<year>2007</year>) <volume>149</volume>:<fpage>70</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2249.2007.03388.x</pub-id><pub-id pub-id-type="pmid">17425654</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Jong</surname><given-names>A</given-names></name></person-group>
<article-title>Activation of human T-cells by CD1 and self-lipids</article-title>. <source>Immunol Rev</source> (<year>2015</year>) <volume>267</volume>(<issue>1</issue>):<fpage>16</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="doi">10.111/imr.12322</pub-id><pub-id pub-id-type="pmid">26284469</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uldrich</surname><given-names>AP</given-names></name><name><surname>Le Nours</surname><given-names>J</given-names></name><name><surname>Pellicci</surname><given-names>DG</given-names></name><name><surname>Gherardin</surname><given-names>NA</given-names></name><name><surname>McPherson</surname><given-names>KG</given-names></name><name><surname>Lim</surname><given-names>RT</given-names></name><etal/></person-group>
<article-title>CD1d-lipid antigen recognition by the &#x003b3;&#x003b4; TCR</article-title>. <source>Nat Immunol</source> (<year>2013</year>) <volume>14</volume>(<issue>11</issue>):<fpage>1137</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1038/ni.2713</pub-id><pub-id pub-id-type="pmid">24076636</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabelitz</surname><given-names>D</given-names></name><name><surname>Lettau</surname><given-names>M</given-names></name><name><surname>Janssen</surname><given-names>O</given-names></name></person-group>. <article-title>Immunosurveillance by human &#x003b3;&#x003b4; T lymphocytes: the emerging role of butyrophilins</article-title>. <source>F100Res</source> (<year>2017</year>) <volume>6</volume>:<fpage>782</fpage>.<pub-id pub-id-type="doi">10.12688/f1000research.11057</pub-id><?supplied-pmid 28649364?><pub-id pub-id-type="pmid">28649364</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasudev</surname><given-names>A</given-names></name><name><surname>Ying</surname><given-names>CTT</given-names></name><name><surname>Ayyadhury</surname><given-names>S</given-names></name><name><surname>Puan</surname><given-names>KJ</given-names></name><name><surname>Andiappan</surname><given-names>AK</given-names></name><name><surname>Nyunt</surname><given-names>MSZ</given-names></name><etal/></person-group>
<article-title>&#x003b3;/&#x003b4; T cell subsets in human aging use the classical &#x003b1;/&#x003b2; T cell model</article-title>. <source>J Leukoc Biol</source> (<year>2014</year>) <volume>8</volume>:<fpage>647</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.5A1213-650RR</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Dongen</surname><given-names>JJM</given-names></name><name><surname>Langerak</surname><given-names>AW</given-names></name><name><surname>Br&#x000fc;ggeman</surname><given-names>M</given-names></name><name><surname>Evans</surname><given-names>PAS</given-names></name><name><surname>Hummel</surname><given-names>M</given-names></name><name><surname>Lavender</surname><given-names>FL</given-names></name><etal/></person-group>
<article-title>Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936</article-title>. <source>Leukemia</source> (<year>2003</year>) <volume>17</volume>:<fpage>2257</fpage>&#x02013;<lpage>317</lpage>.<pub-id pub-id-type="doi">10.1038/sj.leu.2403202</pub-id><?supplied-pmid 14671650?><pub-id pub-id-type="pmid">14671650</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandberg</surname><given-names>Y</given-names></name><name><surname>Verhaaf</surname><given-names>B</given-names></name><name><surname>van Gastel-Mol</surname><given-names>EJ</given-names></name><name><surname>Wolvers-Tettero</surname><given-names>ILM</given-names></name><name><surname>de Vos</surname><given-names>AW</given-names></name><name><surname>Noordzij</surname><given-names>JG</given-names></name><etal/></person-group>
<article-title>Human T-cell lines with well-defined T-cell receptor gene rearrangements as controls for the BIOMED-2 multiplex polymerase chain reaction tubes</article-title>. <source>Leukemia</source> (<year>2007</year>) <volume>21</volume>:<fpage>230</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1038/sj.leu.2404486</pub-id><?supplied-pmid 17170727?><pub-id pub-id-type="pmid">17170727</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moorhouse</surname><given-names>MJ</given-names></name><name><surname>van Zessen</surname><given-names>D</given-names></name><name><surname>Ijspeert</surname><given-names>H</given-names></name><name><surname>Hiltemann</surname><given-names>S</given-names></name><name><surname>Horsman</surname><given-names>S</given-names></name><name><surname>van der Spek</surname><given-names>PJ</given-names></name><etal/></person-group>
<article-title>ImmunoGlobulin galaxy (IGGalaxy) for simple determination and quanti-tation of immunoglobulin heavy chain rearrangements from NGS</article-title>. <source>BMC Immunol</source> (<year>2014</year>) <volume>15</volume>:<fpage>59</fpage>.<pub-id pub-id-type="doi">10.1186/s12865-014-0059-7</pub-id><?supplied-pmid 25495099?><pub-id pub-id-type="pmid">25495099</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goecks</surname><given-names>J</given-names></name><name><surname>Nekrutenko</surname><given-names>A</given-names></name><name><surname>Taylor</surname><given-names>J</given-names></name><collab>The Galaxy Team</collab></person-group>. <article-title>Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences</article-title>. <source>Genome Biol</source> (<year>2010</year>) <volume>11</volume>(<issue>8</issue>):<fpage>R86</fpage>.<pub-id pub-id-type="doi">10.1186/gb-2010-11-8-r86</pub-id><?supplied-pmid 20738864?><pub-id pub-id-type="pmid">20738864</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blankenberg</surname><given-names>D</given-names></name><name><surname>Von Kuster</surname><given-names>G</given-names></name><name><surname>Coraor</surname><given-names>N</given-names></name><name><surname>Ananda</surname><given-names>G</given-names></name><name><surname>Lazarus</surname><given-names>R</given-names></name><name><surname>Mangan</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Galaxy: a web-based genome analysis tool for experimentalists</article-title>. <source>Curr Protoc Mol Biol</source> (<year>2010</year>) <volume>19</volume>:<fpage>.1</fpage>&#x02013;<lpage>.21</lpage>.<pub-id pub-id-type="doi">10.1002/0471142727.mb1910s89</pub-id><?supplied-pmid 20069535?><pub-id pub-id-type="pmid">20069535</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giardine</surname><given-names>B</given-names></name><name><surname>Riemer</surname><given-names>C</given-names></name><name><surname>Hardison</surname><given-names>RC</given-names></name><name><surname>Burhans</surname><given-names>R</given-names></name><name><surname>Elnitski</surname><given-names>L</given-names></name><name><surname>Shah</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Galaxy: a platform for interactive large-scale genome analysis</article-title>. <source>Genome Res</source> (<year>2005</year>) <volume>15</volume>(<issue>10</issue>):<fpage>1451</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1101/gr.4086505</pub-id><?supplied-pmid 16169926?><pub-id pub-id-type="pmid">16169926</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blankenberg</surname><given-names>D</given-names></name><name><surname>Gordon</surname><given-names>A</given-names></name><name><surname>Von Kuster</surname><given-names>G</given-names></name><name><surname>Coraor</surname><given-names>N</given-names></name><name><surname>Taylor</surname><given-names>J</given-names></name><name><surname>Nekrutenko</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Manipulation of FASTQ data with galaxy</article-title>. <source>Bioinformatics</source> (<year>2010</year>) <volume>26</volume>(<issue>14</issue>):<fpage>1783</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1093/bioinformatics/btg281</pub-id><?supplied-pmid 20562416?><pub-id pub-id-type="pmid">20562416</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alamyar</surname><given-names>E</given-names></name><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Shuo</surname><given-names>L</given-names></name><name><surname>Duroux</surname><given-names>P</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT/HighV-QUEST: the IMGT<sup>&#x000ae;</sup> web portal for immunoglobulin (IG) or antibody and T-cell receptor (TR) analysis from NGS high throughput and deep sequencing</article-title>. <source>Immunome Res</source> (<year>2012</year>) <volume>8</volume>(<issue>1</issue>):<fpage>26</fpage><pub-id pub-id-type="doi">10.1007/978-1-61779-842-9_32</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alamyar</surname><given-names>E</given-names></name><name><surname>Duroux</surname><given-names>P</given-names></name><name><surname>Lefranc</surname><given-names>MP</given-names></name><name><surname>Giudicelli</surname><given-names>V</given-names></name></person-group>
<article-title>IMGT(<sup>&#x000ae;</sup>) tools for the nucleotide analysis of immunoglobulin (IG) and T-cell receptor (TR) V-(D)-J repertoires, polymorphisms, and IG mutations: IMGT/V-QUEST and IMGT/HighV-QUEST for NGS</article-title>. <source>Methods Mol Biol</source> (<year>2012</year>) <volume>882</volume>:<fpage>569</fpage>&#x02013;<lpage>604</lpage>.<pub-id pub-id-type="doi">10.1007/987-1-61779-842-9_32</pub-id><pub-id pub-id-type="pmid">22665256</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Lefranc</surname><given-names>MP</given-names></name><name><surname>Miles</surname><given-names>JJ</given-names></name><name><surname>Alamyar</surname><given-names>E</given-names></name><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Duroux</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>IMGT/HighV QUEST paradigm for T-cell receptor IMGT clonotype diversity and next-generation repertoire immunoprofiling</article-title>. <source>Nat Commun</source> (<year>2013</year>) <volume>4</volume>:<fpage>2333</fpage><pub-id pub-id-type="doi">10.1038/ncomms3333</pub-id><pub-id pub-id-type="pmid">23995877</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Duroux</surname><given-names>P</given-names></name><name><surname>Lavoie</surname><given-names>A</given-names></name><name><surname>Aouinti</surname><given-names>S</given-names></name><name><surname>Lefranc</surname><given-names>MP</given-names></name><name><surname>Kossida</surname><given-names>S</given-names></name></person-group>
<article-title>From IMGT-ONTOLOGY to IMGT/HighVQUEST for NGS Immunoglobulin (IG) and T-cell receptor (TR) repertoires in autoimmune and infectious diseases</article-title>. <source>Autoimmun Infect Dis</source> (<year>2015</year>) <volume>1</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="doi">10.16966/aidoa.103</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyd</surname><given-names>SD</given-names></name><name><surname>Marshall</surname><given-names>EL</given-names></name><name><surname>Merker</surname><given-names>JD</given-names></name><name><surname>Maniar</surname><given-names>JM</given-names></name><name><surname>Zhang</surname><given-names>LN</given-names></name><name><surname>Sahaf</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing</article-title>. <source>Sci Transl Med</source> (<year>2009</year>) <volume>1</volume>(<issue>12</issue>):<fpage>12ra23</fpage>.<pub-id pub-id-type="doi">10.1126/scitranslmed.3000540</pub-id><?supplied-pmid 20161664?><pub-id pub-id-type="pmid">20161664</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krzywinksi</surname><given-names>MI</given-names></name><name><surname>Schein</surname><given-names>JE</given-names></name><name><surname>Birol</surname><given-names>I</given-names></name><name><surname>Connors</surname><given-names>J</given-names></name><name><surname>Gascoyne</surname><given-names>R</given-names></name><name><surname>Horsman</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Circos: an information aesthetic for comparative genomic</article-title>. <source>Genome Res</source> (<year>2009</year>) <volume>19</volume>:<fpage>1639</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1101/gr.092759.109</pub-id><pub-id pub-id-type="pmid">19541911</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crooks</surname><given-names>GE</given-names></name><name><surname>Hon</surname><given-names>G</given-names></name><name><surname>Chandonia</surname><given-names>JM</given-names></name><name><surname>Brenner</surname><given-names>SE</given-names></name></person-group>. <article-title>WebLogo: a sequence logo generator</article-title>. <source>Genome Res</source> (<year>2004</year>) <volume>14</volume>:<fpage>1188</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.1101/gr.849004</pub-id><?supplied-pmid 15173120?><pub-id pub-id-type="pmid">15173120</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>TD</given-names></name><name><surname>Stephens</surname><given-names>RM</given-names></name></person-group>. <article-title>Sequence logos: a new way to display consensus sequences</article-title>. <source>Nucleic Acids Res</source> (<year>1990</year>) <volume>18</volume>:<fpage>6097</fpage>&#x02013;<lpage>100</lpage>.<pub-id pub-id-type="doi">10.1093/nar/18.20.6097</pub-id><?supplied-pmid 2172928?><pub-id pub-id-type="pmid">2172928</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartigan</surname><given-names>PM</given-names></name></person-group>
<article-title>Algorithm AS 217: computation of the dip statistic to test for unimodality</article-title>. <source>Appl Stat</source> (<year>1985</year>) <volume>34</volume>:<fpage>320</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.2307/2347485</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartigan</surname><given-names>JA</given-names></name><name><surname>Hartigan</surname><given-names>PM</given-names></name></person-group>
<article-title>The dip test of unimodality</article-title>. <source>Ann Stat</source> (<year>1985</year>) <volume>13</volume>:<fpage>70</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1214/aos/1176346577</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>M&#x000e4;chler</surname><given-names>M</given-names></name></person-group>
<source>Diptest 0.25-1</source>. (<year>2003</year>). Available from: <uri xlink:type="simple" xlink:href="http://www.r-project.org/">http://www.r-project.org/</uri></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Core Team</surname><given-names>R</given-names></name></person-group>
<article-title>R: a language and environment for statistical computing</article-title>. <source>R Foundation for Statistical Computing</source>. <publisher-loc>Vienna, Austria</publisher-loc> (<year>2016</year>). <uri xlink:type="simple" xlink:href="https://www.R-project.org">https://www.R-project.org</uri></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liston</surname><given-names>A</given-names></name><name><surname>Carr</surname><given-names>EJ</given-names></name><name><surname>Linterman</surname><given-names>MA</given-names></name></person-group>
<article-title>Shaping variation in the human immune system</article-title>. <source>Trends Immunol</source> (<year>2016</year>) <volume>36</volume>(<issue>10</issue>):<fpage>637</fpage>&#x02013;<lpage>46</lpage>.<pub-id pub-id-type="doi">10.1016/j.it.2016.08.002</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kallemeijn</surname><given-names>MJ</given-names></name><name><surname>Boots</surname><given-names>AMH</given-names></name><name><surname>van der Klift</surname><given-names>MY</given-names></name><name><surname>Brouwer</surname><given-names>E</given-names></name><name><surname>Abdulahad</surname><given-names>WH</given-names></name><name><surname>Verhaar</surname><given-names>JAN</given-names></name><etal/></person-group>
<article-title>Ageing and latent CMV infection impact on maturation, differentiation and exhaustion profiles of T-cell receptor gammadelta T-cells</article-title>. <source>Sci Rep</source> (<year>2017</year>) <volume>7</volume>:<fpage>5509</fpage>.<pub-id pub-id-type="doi">10.1038/s41598-017-05849-1</pub-id><?supplied-pmid 28710491?><pub-id pub-id-type="pmid">28710491</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Correia</surname><given-names>DV</given-names></name><name><surname>d&#x02019;Orey</surname><given-names>F</given-names></name><name><surname>Cardoso</surname><given-names>BA</given-names></name><name><surname>Lan&#x000e7;a</surname><given-names>T</given-names></name><name><surname>Grosso</surname><given-names>AR</given-names></name><name><surname>deBarros</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Highly active microbial phosphoantigen induces rapid yet sustained MEK/Erk- and PI-3K/Akt-mediated signal transduction in anti-tumor human gammadelta T-cells</article-title>. <source>PLoS One</source> (<year>2009</year>) <volume>4</volume>(<issue>5</issue>):<fpage>e5657</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0005657</pub-id><?supplied-pmid 19479075?><pub-id pub-id-type="pmid">19479075</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ijspeert</surname><given-names>H</given-names></name><name><surname>van Schouwenburg</surname><given-names>PA</given-names></name><name><surname>van Zessen</surname><given-names>D</given-names></name><name><surname>Pico-Knijnenburg</surname><given-names>I</given-names></name><name><surname>Stubbs</surname><given-names>AP</given-names></name><name><surname>van der Burg</surname><given-names>M</given-names></name></person-group>. <article-title>Antigen receptor galaxy: a user-friendly, web-based tool for analysis and visualization of T and B cell receptor repertoire data</article-title>. <source>J Immunol</source> (<year>2017</year>) <volume>198</volume>:<fpage>4156</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1601924</pub-id><?supplied-pmid 28416602?><pub-id pub-id-type="pmid">28416602</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>CT</given-names></name><name><surname>Abate</surname><given-names>G</given-names></name><name><surname>Blazevic</surname><given-names>A</given-names></name><name><surname>Hoft</surname><given-names>DF</given-names></name></person-group>
<article-title>Only a subset of phosphoantigen-responsive gamma9delta2 T-cells mediate protective tuberculosis immunity</article-title>. <source>J Immunol</source> (<year>2008</year>) <volume>181</volume>:<fpage>4471</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.181.7.4471</pub-id><pub-id pub-id-type="pmid">18802050</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandberg</surname><given-names>Y</given-names></name><name><surname>Kallemeijn</surname><given-names>MJ</given-names></name><name><surname>Dik</surname><given-names>WA</given-names></name><name><surname>Tielemans</surname><given-names>D</given-names></name><name><surname>Wolvers-Tettero</surname><given-names>ILM</given-names></name><name><surname>van Gastel-Mol</surname><given-names>EJ</given-names></name><etal/></person-group>
<article-title>Lack of common TCRA and TCRB clonotypes in CD8(+)/TCR&#x003b1;&#x003b2;(+) T-cell large granular lymphocyte leukemia: a review on the role of antigenic selection in the immunopathogenesis of CD8(+) T-LGL</article-title>. <source>Blood Cancer J</source> (<year>2014</year>) <volume>10</volume>(<issue>4</issue>):<fpage>e172</fpage>.<pub-id pub-id-type="doi">10.1038/bcj.2013.70</pub-id><?supplied-pmid 24413066?><pub-id pub-id-type="pmid">24413066</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kallemeijn</surname><given-names>MJ</given-names></name><name><surname>de Ridder</surname><given-names>D</given-names></name><name><surname>Schilperoord-Vermeulen</surname><given-names>J</given-names></name><name><surname>van der Klift</surname><given-names>MY</given-names></name><name><surname>Sandberg</surname><given-names>Y</given-names></name><name><surname>van Dongen</surname><given-names>JJ</given-names></name><etal/></person-group>
<article-title>Dysregulated signaling, proliferation and apoptosis impact on the pathogenesis of TCR&#x003b3;&#x003b4;+ T-cell large granular lymphocyte leukemia</article-title>. <source>PLoS One</source> (<year>2017</year>) <volume>12</volume>(<issue>4</issue>):<fpage>e0175670</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0175670</pub-id><pub-id pub-id-type="pmid">28407008</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="book"><collab>World Health Organization</collab>. <source>World Report on Aging and Health</source>. <publisher-loc>Luxembourg</publisher-loc>: <publisher-name>WHO</publisher-name> (<year>2015</year>).</mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naylor</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Vallejo</surname><given-names>AN</given-names></name><name><surname>Lee</surname><given-names>WW</given-names></name><name><surname>Koetz</surname><given-names>K</given-names></name><name><surname>Bryl</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>The influence of age on T cell generation and TCR diversity</article-title>. <source>J Immunol</source> (<year>2005</year>) <volume>174</volume>:<fpage>7446</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.174.11.7446</pub-id><?supplied-pmid 15905594?><pub-id pub-id-type="pmid">15905594</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Appay</surname><given-names>V</given-names></name><name><surname>Sauce</surname><given-names>D</given-names></name></person-group>. <article-title>Naive T cells: the crux of cellular immune aging?</article-title>
<source>Exp Gerontol</source> (<year>2014</year>) <volume>54</volume>:<fpage>90</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="doi">10.1016/j.exger.2014.01.003</pub-id><?supplied-pmid 24440387?><pub-id pub-id-type="pmid">24440387</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>K</given-names></name><name><surname>Cologne</surname><given-names>JB</given-names></name><name><surname>Cordova</surname><given-names>K</given-names></name><name><surname>Misumi</surname><given-names>M</given-names></name><name><surname>Yamoaka</surname><given-names>M</given-names></name><name><surname>Kyoizumi</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Aging-related changes in human T-cell repertoire over 20 years delineated by deep sequencing of peripheral T-cell receptors</article-title>. <source>Exp Gerontol</source> (<year>2017</year>) <volume>96</volume>:<fpage>29</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="doi">10.1016/j.exger.2017.05.015</pub-id><?supplied-pmid 28535950?><pub-id pub-id-type="pmid">28535950</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>SE</given-names></name><name><surname>Sedikides</surname><given-names>GX</given-names></name><name><surname>Okecha</surname><given-names>G</given-names></name><name><surname>Poole</surname><given-names>EL</given-names></name><name><surname>Sinclair</surname><given-names>JH</given-names></name><name><surname>Wills</surname><given-names>MR</given-names></name></person-group>. <article-title>Latent cytomegalovirus (CMV) infection does not detrimentally alter T cell responses in the healthy old, but increased latent CMV carriage is related to expanded CMV-specific T cells</article-title>. <source>Front Immunol</source> (<year>2017</year>) <volume>8</volume>:<fpage>733</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2017.00733</pub-id><?supplied-pmid 28694811?><pub-id pub-id-type="pmid">28694811</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merani</surname><given-names>S</given-names></name><name><surname>Pawelec</surname><given-names>G</given-names></name><name><surname>Kuchel</surname><given-names>GA</given-names></name><name><surname>McElhaney</surname><given-names>JE</given-names></name></person-group>. <article-title>Impact of aging and Cytomegalovirus on immunological response to Influenza vaccination and infection</article-title>. <source>Front Immunol</source> (<year>2017</year>) <volume>8</volume>:<fpage>784</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2017.00784</pub-id><?supplied-pmid 28769922?><pub-id pub-id-type="pmid">28769922</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vantourout</surname><given-names>P</given-names></name><name><surname>Hayday</surname><given-names>A</given-names></name></person-group>
<article-title>Six-of-the-best: unique contributions of &#x003b3;&#x003b4; T-cells to immunology</article-title>. <source>Nat Rev Immunol</source> (<year>2013</year>) <volume>13</volume>(<issue>2</issue>):<fpage>88</fpage>&#x02013;<lpage>100</lpage>.<pub-id pub-id-type="doi">10.1038/nri3384</pub-id><pub-id pub-id-type="pmid">23348415</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chien</surname><given-names>YH</given-names></name><name><surname>Meyer</surname><given-names>C</given-names></name><name><surname>Bonneville</surname><given-names>M</given-names></name></person-group>
<article-title>&#x003b3;&#x003b4; T cells: first line of defense and beyond</article-title>. <source>Annu Rev Immunol</source> (<year>2014</year>) <volume>32</volume>:<fpage>121</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1146/annurev-immunol-032713-120216</pub-id><pub-id pub-id-type="pmid">24387714</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>MM</given-names></name><name><surname>Witherden</surname><given-names>DA</given-names></name><name><surname>Havran</surname><given-names>WL</given-names></name></person-group>. <article-title>&#x003b3;&#x003b4; T cells in homeostasis and host defence of epithelial barrier tissues</article-title>. <source>Nat Rev Immunol</source> (<year>2017</year>) <volume>17</volume>(<issue>12</issue>):<fpage>733</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1038/nri.2017.101</pub-id><?supplied-pmid 28920588?><pub-id pub-id-type="pmid">28920588</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davey</surname><given-names>MS</given-names></name><name><surname>Wlicox</surname><given-names>CR</given-names></name><name><surname>Joyce</surname><given-names>SP</given-names></name><name><surname>Ladell</surname><given-names>K</given-names></name><name><surname>Kasatskaya</surname><given-names>SA</given-names></name><name><surname>McLaren</surname><given-names>JE</given-names></name><etal/></person-group>
<article-title>Clonal selection in the human V&#x003b4;1 T cell repertoire indicates &#x003b3;&#x003b4; TCR-dependent adaptive immune surveillance</article-title>. <source>Nat Commun</source> (<year>2017</year>) <volume>8</volume>:<fpage>14760</fpage>.<pub-id pub-id-type="doi">10.1038/ncomms14760</pub-id><?supplied-pmid 28248310?><pub-id pub-id-type="pmid">28248310</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Godder</surname><given-names>KT</given-names></name><name><surname>Henslee-Downey</surname><given-names>PJ</given-names></name><name><surname>Mehta</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>BS</given-names></name><name><surname>Chiang</surname><given-names>KY</given-names></name><name><surname>Abhyankar</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation</article-title>. <source>Bone Marrow Transplant</source> (<year>2007</year>) <volume>39</volume>(<issue>12</issue>):<fpage>751</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1038/sj.bmt.1705650</pub-id><?supplied-pmid 17450185?><pub-id pub-id-type="pmid">17450185</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wistuba-Hamprecht</surname><given-names>K</given-names></name><name><surname>Di Benedetto</surname><given-names>S</given-names></name><name><surname>Schilling</surname><given-names>B</given-names></name><name><surname>Sucker</surname><given-names>A</given-names></name><name><surname>Schadendorf</surname><given-names>D</given-names></name><name><surname>Garbe</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Phenotypic characterization and prognostic impact of circulating &#x003b3;&#x003b4; and &#x003b1;&#x003b2; T-cells in metastatic malignant melanoma</article-title>. <source>Int J Cancer</source> (<year>2016</year>) <volume>138</volume>(<issue>3</issue>):<fpage>698</fpage>&#x02013;<lpage>704</lpage>.<pub-id pub-id-type="doi">10.1002/ijc.29818</pub-id><pub-id pub-id-type="pmid">26383054</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lafont</surname><given-names>V</given-names></name><name><surname>Sanchez</surname><given-names>F</given-names></name><name><surname>Laprevotte</surname><given-names>E</given-names></name><name><surname>Michaud</surname><given-names>HA</given-names></name><name><surname>Gros</surname><given-names>L</given-names></name><name><surname>Eliaou</surname><given-names>JF</given-names></name><etal/></person-group>
<article-title>Plasticity of &#x003b3;&#x003b4; T cells: impact on the anti-tumor response</article-title>. <source>Front Immunol</source> (<year>2014</year>) <volume>5</volume>:<fpage>662</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2014.00622</pub-id><pub-id pub-id-type="pmid">25584044</pub-id></mixed-citation></ref></ref-list></back></article>